Multiple clinical reviews and case reports demonstrate that Ginkgo biloba can interact negatively with prescription psychotropic and antidepressant medications, increasing the risk of adverse effects such as bleeding complications and altered drug metabolism.
The claim is specific and falsifiable, passing Step 0. The retrieved literature (e.g., papers 1, 3, 5, 8, and 10) consistently documents that Ginkgo biloba causes pharmacokinetic and pharmacodynamic herb-drug interactions, particularly with psychotropic medications like antidepressants (SSRIs/SNRIs) and sedatives, leading to adverse clinical outcomes.